Osiris Therapeutics CFO resigns; interim replacement named
Insight Weekly: US inflation soars; real estate faces slowdown; megadeals drive tech M&A
Commercial Banking: June 22nd Edition
Understanding Loss Given Default A Review of Three Approaches
Insight Weekly: Path to net-zero; US manufacturing momentum; China's lithium M&A frenzy
Osiris Therapeutics Inc. said Linda Chang resigned as the company's CFO.
The Columbia, Md.-based maker of regenerative medicine named Joel Rogers interim CFO.
Rogers has been Osiris Therapeutics' corporate controller since October 2017, and was previously corporate controller at industrial equipment maker ARC Group Worldwide, Inc.